Preclinical and clinical properties of elbasvir (ERELSA®...

Preclinical and clinical properties of elbasvir (ERELSA® Tablets 50 mg) and Grazoprevir (GRAZYNA® Tablets 50 mg), novel therapeutic agents for hepatitis C

Kinoshita, Kiyoshi, Iwasa, Takashi, Asante-Appiah, Ernest, Nakamura, Keisuke
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
150
Year:
2017
Journal:
Folia Pharmacologica Japonica
DOI:
10.1254/fpj.150.41
File:
PDF, 1.21 MB
2017
Conversion to is in progress
Conversion to is failed